Document is current
Any future updates will be listed below
-
Authors
Godin, Philippe https://orcid.org/0000-0003-0857-6891
Nagykery, Nicholas
Sicher, Natalie
Barnes, Julie L. https://orcid.org/0000-0002-7314-2574
Miller, Amy G.
Bunner, Christina
Thompson, Amy K. https://orcid.org/0000-0002-8611-4767
Kano, Motohiro
Gao, Guangping https://orcid.org/0000-0003-0097-9012
Wang, Dan https://orcid.org/0000-0001-9079-2360
Donahoe, Patricia K.
Rhodes, Linda
Brake, David A.
Conlon, Thomas J.
Swanson, William F. https://orcid.org/0000-0003-4067-0319
Vansandt, Lindsey M. https://orcid.org/0000-0002-5951-2057
Pépin, David https://orcid.org/0000-0003-2046-6708
-
Funding
Funding for this research was provided by:
Michelson Prize and Grants (MG14-S06)
Fonds de Recherche du Québec - Nature et Technologies (313511)
Fonds de Recherche du Québec - Nature et Technologies (356514)
Joanie Bernard Foundation Huiying Foundation Patricia K. Donahoe, MD, Surgeon-Scientist Research Program Sudna-Gar Fund
- License Information
-
More Information
Article History
Received: 16 May 2025
Accepted: 22 October 2025
First Online: 28 November 2025
Competing interests
: The authors declare the following competing interests: Employees and advisors of The Michelson Found Animals Foundation were involved in the conceptualization and design of the study (L.R., D.A.B., and T.J.C.). P.K.D. and D.P. are co-inventors in the patent application #US 2024/0218038 A1, which relates to compositions and methods of reducing fertility in prepubescent non-human subjects by administering a composition comprising a vector comprising a nucleic acid encoding an anti-Müllerian hormone (AMH, also Mullerian inhibiting substance, MIS) protein. The remaining authors declare no competing interests.
